echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Antitumor Therapy > LANCET: Cancer Incidence in Children and Adolescents in China Exposed!

    LANCET: Cancer Incidence in Children and Adolescents in China Exposed!

    • Last Update: 2022-09-30
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Cancer is one of the leading causes of
    death in children and adolescents worldwide.


    On September 24, 2022, the National Childhood Cancer Surveillance Center (NCPCS) assessed the differences in cancer incidence in children and adolescents in China from the
    perspective of socioeconomic inequality 。 The findings were published in "The Lancet" under the title "Socioeconomic inequalities in cancer incidence and access to health services among children and adolescents in China: a cross-sectional study.


    In this nationwide cross-sectional study, the researchers used data from the National Children's Cancer Surveillance Center, the National Hospital Quality Monitoring System and public databases to cover 31 provinces, autonomous regions and municipalities
    directly under the Central Government of mainland China.


    Use the Human Development Index (HDI) to classify
    areas by socioeconomic status.


    Results of the study

    1.


    Leukemia (42.


    3.


    4.


    5.


    1.


    From January 1, 2018 to December 31, 2020, an estimated 121145 children and adolescents in China have been diagnosed with cancer, and the average incidence of the world standard age standardization is 126.


    Leukemia (42.


    Malignant epithelial tumors and melanoma, leukemia, and central nervous system tumors are the three most common cancer types
    among adolescents.


    Neuroblastoma and ganglion neuroblastoma are the most common types of cancer in girls and boys under 1 year of age, accounting for 15.


    In people aged 1 year and older, the incidence of precursor cell leukemia was highest in all groups, with the exception of adolescent girls, with the highest
    incidence of thyroid cancer.


    3.


    Although there are some fluctuations between different age groups, the overall incidence of childhood cancer increases with increasing HDI (p<0.
    0001
    ).

    In different HDI regions, the rate of change is greater for girls than for boys
    .
    Data on the total incidence of cancer in adolescents also increased with increasing HDI levels (p<0.
    0001), but fluctuated greater
    .

    In children, a clear trend
    was observed in which the incidence of lymphoma, central nervous system tumors, neuroblastoma, retinoblastoma, malignant bone tumors, and soft-tissue sarcoma increased with increasing HDI levels.

    4.
    Population and geographic density in most health services are also significantly positively correlated with HDI levels

    The geographical density of all health services (Gini coefficient 0.
    32–0.
    47) is more unequal than population density (Gini coefficient 0.
    05–0.
    19).

    The geographical density of all health services increased significantly with the increase in HDI (diagnostic and therapeutic institutions p=0.
    012, pediatric beds p=0.
    0050, pediatric oncologists p=0.
    012, pathology p=0.
    0060 labour), while population densities of only pediatric oncologists (p=0.
    049) and pathological labour (p=0.
    0090) were significantly positively correlated
    with HDI levels.

    In the areas with the highest geographical and population densities in almost all health services, the incidence of cancer among adolescents has dropped
    dramatically.

    5.
    The overall proportion of patients with cancer in children and adolescents across regions was 22.
    16%, of which retinoblastoma (56.
    54%) and low HDI regions (35.
    14%) had the highest proportion

    The overall proportion of patients with cross-regional patients in new cases of cancer in children and adolescents was 22.
    16%, with retinoblastoma (56.
    54%) and low HDI region (35.
    14%) having the highest
    proportion.
    HDI levels declined in the 11 major cancer groups, but with the exception of central nervous system tumors, kidney tumors, liver tumors, and soft-tissue sarcomas, there were some fluctuations between most groups, but a clear trend
    towards an increase in the proportion of patients across regions was observed.

    Conclusion of this article

    In conclusion, this paper reveals the heavy burden
    of cancer in children and adolescents in our country by combining cancer incidence and data obtained by health services.
    As a social determinant of health, the distribution of access to health services may play a significant role in the socio-economy
    .
    To achieve the Sustainable Development Goals, policies should prioritize increasing access to early diagnosis health services to improve outcomes and subsequently reduce the burden of disease, and reduce socioeconomic inequalities in
    childhood and adolescent cancer.

    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.